Please ensure Javascript is enabled for purposes of website accessibility
Patrick Bafuma

Patrick Bafuma


Recent articles


Buy the Dip on These 3 Healthcare Stocks

Here's why our roundtable likes Vir Biotechnology, OrthoPediatrics, and Vertex Pharmaceuticals.


Novartis Is Looking for Deals. Are These 3 Biotechs on Its List?

CEO Vas Narasimhan is seeking acquisitions under $2 billion.

These Charts Explain Why I'm Holding This Healthcare Company

Transplants are in high demand; this company is making the process of getting one smoother.

2 Healthcare Stocks That Could Go Parabolic

These two companies are poised for a comeback.


This Chart Is Why I'm Not Worried About Guardant Health

The leading innovator in the liquid biopsy space has huge addressable markets ahead of it.


Why I'm Over the Moon for This Healthcare Stock -- In One Chart

This company helps keep patients at home with dialysis treatments.


Things Just Got Worse for Biogen

The company just withdrew its Aduhelm regulatory submission in the EU.


Missed Intuitive Surgical? Buy This Stock Instead

Much as Intuitive Surgical redefined the surgical field, this company is updating how abnormal heart rhythms are diagnosed.

This Chart Is Why I'm Holding This Stock for the Next Decade

This biotech's products are a must-have for scientists.

2 Medtech Stocks You Can Buy and Hold for the Next Decade

These two companies are leading the charge for improved patient outcomes.


2 Under-the-Radar Biotech Stocks to Buy in 2022

Both companies have catalysts for explosive growth this year.


2 Top Biotech Stocks to Buy in April

These shares are down significantly from all-time highs, but the businesses have plenty of room for growth.

2 Top Biotech Stocks to Buy for the Long Haul

Repligen and Exact Sciences have a proven track record with significant opportunities for continued growth.


3 Healthcare Stocks to Buy and Hold for the Next 10 Years

These companies have a history of creating shareholder value -- and still have plenty of room for growth.


2 Biotechs With Recent FDA Approvals to Hold for the Next Decade

With trials aimed at increasing addressable markets in the coming years, Legend and Immunocore could reward investors.

Customers Love These 3 Healthcare Companies

Net Promoter Scores can provide insights into customer satisfaction, and possibly lead to market-beating returns.


3 Last-Minute Healthcare Stocking Stuffers

Here are three stocks sure to pique the interest of that special someone.


10x Genomics Stock: Bull vs. Bear

After a hot start, the stock has recently lagged the market. Is now a good time to buy?


Better Buy: Ocugen or Novavax?

Will either of these hopeful vaccine makers continue to thrash the market?


Better Buy: Bristol Myers Squibb vs. Merck

Which pharma giant is right for you?

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.